China National Accord Medicines Corporation Ltd. (200028.SZ)
HKD 14.39
(-0.76%)
HKD 14.39
(-0.76%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.93 Billion | 2.56 Billion | 1.65 Billion | 1.5 Billion | 2 Billion | 1.32 Billion |
| Net Income | 1.95 Billion | 1.77 Billion | 1.52 Billion | 1.72 Billion | 1.48 Billion | 1.34 Billion |
| Depreciation & Amortization | 1.42 Billion | 1.3 Billion | 1.26 Billion | 1.05 Billion | 791.62 Million | 116.25 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -519.86 Million | -1.01 Billion | -1.31 Billion | -1.28 Billion | -278.48 Million | 24.03 Million |
| Other non-cash items | 72.86 Million | 496.17 Million | 178.26 Million | 7.47 Million | 2.98 Million | -166.11 Million |
| Investing Cash Flow | -135.43 Million | -342.81 Million | -455.53 Million | -2.78 Billion | -240.44 Million | -222.45 Million |
| Investments in PPE | -322.2 Million | -322.19 Million | -370.43 Million | -293.82 Million | -245.16 Million | -255.48 Million |
| Acquisitions | 3.22 Million | -126.35 Million | -109.95 Million | -2.64 Billion | -97.01 Million | 2.46 Million |
| Investment purchases | -8.74 Million | -74.89 Million | -147.02 Million | -50.11 Million | -56 Million | -124.57 Million |
| Sales/Maturities of investments | 160.18 Million | 164.55 Million | 172.1 Million | 179.19 Million | 151.84 Million | 131.4 Million |
| Other Investing Activities | 32.1 Million | 16.06 Million | -234.52 Thousand | 27.61 Million | 5.89 Million | 23.72 Million |
| Financing Cash Flow | -2.4 Billion | -1.5 Billion | -1.87 Billion | -1.74 Billion | -969.16 Million | 2.85 Billion |
| Debt repayment | -1.78 Billion | -1.53 Billion | -1 Billion | -427.34 Million | -99.84 Million | -79.67 Million |
| Dividends payments | -559.07 Million | -574.18 Million | -610.53 Million | -549.9 Million | -493.05 Million | -273.83 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -1.82 Billion | 604 Million | -254.04 Million | -763.17 Million | -379.31 Million | 3.21 Billion |
| Accounts receivables | -3.99 Billion | 1.22 Billion | -2.12 Billion | -2.98 Billion | -793.3 Million | -1.66 Billion |
| Accounts payables | 3.99 Billion | -1.22 Billion | 2.12 Billion | 2.98 Billion | 793.3 Million | - |
| Inventory | -170.13 Million | -217.83 Million | -1.25 Billion | -406.38 Million | -524.15 Million | -608.95 Million |
| Other working capital | -349.73 Million | -797.07 Million | -59.07 Million | -877.54 Million | 245.66 Million | 632.98 Million |
| Cash at beginning of period | 5.44 Billion | 4.73 Billion | 5.4 Billion | 8.42 Billion | 7.63 Billion | 3.67 Billion |
| Cash at end of period | 5.83 Billion | 5.44 Billion | 4.73 Billion | 5.4 Billion | 8.42 Billion | 7.63 Billion |
| Capital Expenditure | -322.2 Million | -322.19 Million | -370.43 Million | -293.82 Million | -245.16 Million | -255.48 Million |
| Effect of forex changes on cash | -941.39 Thousand | -1.18 Million | 390.58 Thousand | -52.53 Thousand | -175.69 Thousand | -310.82 Thousand |
| Net cash flow / Change in cash | 393.12 Million | 708.66 Million | -671.6 Million | -3.02 Billion | 790.55 Million | 3.95 Billion |
| Free Cash Flow | 2.61 Billion | 2.23 Billion | 1.28 Billion | 1.2 Billion | 1.75 Billion | 1.06 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 354.71 Million | 388.77 Million | 409.59 Million | 1.95 Billion | 359.41 Million |
| Depreciation & Amortization | - | 866.09 Million | - | 1.38 Billion | 1.42 Billion | -667.31 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -3.94 Billion | - | -4.24 Billion | -519.86 Million | 7.46 Billion |
| Other non-cash items | - | 4.28 Billion | -1.02 Billion | 3.91 Billion | 72.86 Million | -7.17 Billion |
| Investing Cash Flow | 98.17 Million | -117.42 Million | -51.98 Million | -70.94 Million | -135.43 Million | 8.11 Million |
| Investments in PPE | -64.16 Million | -67.26 Million | -71.9 Million | -97.85 Million | -322.2 Million | -69.93 Million |
| Acquisitions | - | -71.4 Million | - | 0.84 | 3.22 Million | 0.04 |
| Investment purchases | -8.05 Million | -505 Thousand | -4.92 Million | -4.12 Million | -8.74 Million | -1.12 Million |
| Sales/Maturities of investments | 166.73 Million | 16.71 Million | 24.75 Million | 1.01 Million | 160.18 Million | 79.04 Million |
| Other Investing Activities | 3.65 Million | 21.24 Million | 19.91 Million | 30.02 Million | 32.1 Million | 133.24 Thousand |
| Financing Cash Flow | -939.43 Million | -1.16 Billion | 119.03 Million | -392.99 Million | -2.4 Billion | -604.97 Million |
| Debt repayment | -50.13 Million | -194.4 Million | -72.46 Million | -779.56 Million | -1.78 Billion | -258.69 Million |
| Dividends payments | -65.94 Million | -424.02 Million | -59.51 Million | -4.43 Million | -559.07 Million | -80.11 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -823.35 Million | -530.06 Million | 111.23 Million | -192.26 Million | -1.82 Billion | -266.15 Million |
| Accounts receivables | - | -3.65 Billion | - | -3.99 Billion | -3.99 Billion | 6.78 Billion |
| Accounts payables | - | - | - | - | 3.99 Billion | 360.51 Million |
| Inventory | - | -400.84 Million | - | -170.13 Million | -170.13 Million | 672.35 Million |
| Other working capital | - | 105.89 Million | - | -79.9 Million | -349.73 Million | -360.51 Million |
| Cash at beginning of period | 5.54 Billion | 5.26 Billion | 5.83 Billion | 4.82 Billion | 5.44 Billion | 5.44 Billion |
| Cash at end of period | 5.05 Billion | 5.54 Billion | 5.26 Billion | 5.83 Billion | 5.83 Billion | 4.82 Billion |
| Capital Expenditure | -64.16 Million | -67.26 Million | -71.9 Million | -97.85 Million | -322.2 Million | -69.93 Million |
| Effect of forex changes on cash | 24.06 Thousand | -1.22 Million | 2810.99 | 2527.30 | -941.39 Thousand | 12.67 Thousand |
| Net cash flow / Change in cash | -489.52 Million | 279.04 Million | -567.08 Million | 1 Billion | 393.12 Million | -617.64 Million |
| Free Cash Flow | -64.16 Million | 1.49 Billion | -706.05 Million | 1.37 Billion | 2.61 Billion | -90.74 Million |
601139
HMVL
IBOC
OBCN
OASMY
ITHUF